Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Primary Immunodeficiency
For patients with progessive CKD with comorbid conditions, do you adjust IVIG or switch to SCIG to prevent further progession in GFR reduction?
Related Questions
Is there any genetic testing available for the CDHR3 receptor?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
With the difficulty in access to PPSV23 as the new pneumonia vaccine is now standard (non polysaccharide vaccine), have you used MPSV4 (meningococcal) vaccine for evaluation of response to polysaccharide vaccine?
Should the RSV vaccine be administered to pregnant mothers even if it is not seasonally circulating but they are 32-36 weeks pregnant?
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
Has anyone incidentally diagnosed IgA deficiency in a patient who does not present with any recurrent infections?
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?
How would you treat autologous GVHD after a thymic transplant but with no thymopoeisis?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
